Literature DB >> 22407464

Synthesis and evaluation of novel aza-caged Garcinia xanthones.

Xiaojin Zhang1, Xiang Li, Haopeng Sun, Zhengyu Jiang, Lei Tao, Yuan Gao, Qinglong Guo, Qidong You.   

Abstract

Inspired by the therapeutic potential of the simplified caged xanthones, we have developed a chemical strategy for synthesizing novel aza-caged Garcinia analogues through a regioselective Claisen/Diels-Alder cascade reaction. The origin of regioselectivity has been explained using the DFT method. We have further evaluated the cell proliferation and IKKβ inhibitory activities of these compounds and studied their binding mode with IKKβ by molecular docking. The results suggested that the aza-caged scaffold provides a suitable modification site and the introduction of a hydrophobic moiety leads to improvement in the cytotoxicity and IKKβ inhibitory activity. The aza-caged compound 6c exhibited an IC(50) value of 2.68, 2.10, 8.02 μM against the HepG2, A549 cells and IKKβ, respectively. Mechanism studies with 6c showed that the aza-caged compounds induce apoptosis and cell cycle S phase arrest in A549 cells. This journal is © The Royal Society of Chemistry 2012

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407464     DOI: 10.1039/c2ob07088j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Synthesis of 8',11'-dihydrospiro[cyclohexane-1,2'-oxepino[2,3-h] chromen]-4'(3'H)-ones with ring closing metathesis as a key step.

Authors:  Prathima K; Ashok D; Sarasija M; Prabhakar Sripadi; Madhu Vemula; Venkata S Komarraju; Biswajit Gorai; Shyam Prakash
Journal:  RSC Adv       Date:  2018-11-16       Impact factor: 4.036

2.  'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.

Authors:  Xiang Li; Yue Wu; Yanyan Wang; Qidong You; Xiaojin Zhang
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.